Detection of subclonal SETBP1 and JAK3 mutations in juvenile myelomonocytic leukemia using droplet digital PCR

Affiliations

¹ Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.
² Medical Genomics Center, Nagoya University Hospital, Nagoya, Japan.
³ Center for Advanced Medicine and Clinical Research, Nagoya University Hospital, Nagoya, Japan.
⁴ Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan. hideki-muramatsu@med.nagoya-u.ac.jp.
⁵ Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan. ytakaha@med.nagoya-u.ac.jp.

Manabu Wakamatsu et al. Leukemia. 2021 Jan.

. 2021 Jan;35(1):259-263.

doi: 10.1038/s41375-020-0817-x. Epub 2020 Apr 20.

¹ Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.
² Medical Genomics Center, Nagoya University Hospital, Nagoya, Japan.
³ Center for Advanced Medicine and Clinical Research, Nagoya University Hospital, Nagoya, Japan.
⁴ Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan. hideki-muramatsu@med.nagoya-u.ac.jp.
⁵ Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan. ytakaha@med.nagoya-u.ac.jp.

No abstract available

Cited by

The impact of SETBP1 mutations in neurological diseases and cancer.
Kohyanagi N, Ohama T. Kohyanagi N, et al. Genes Cells. 2023 Sep;28(9):629-641. doi: 10.1111/gtc.13057. Epub 2023 Jul 25. Genes Cells. 2023. PMID: 37489294 Free PMC article. Review.
Acute Mast Cell Leukemia Preceded by Malignant Mediastinal Germ Cell Tumor: A Case Report and Literature Review.
Wang H, Chen Y, Lin H, Ni W, Zhang Q, Lan J, Jin L. Wang H, et al. Cancer Manag Res. 2022 May 23;14:1783-1794. doi: 10.2147/CMAR.S363508. eCollection 2022. Cancer Manag Res. 2022. PMID: 35637940 Free PMC article.
Juvenile myelomonocytic leukemia in the molecular era: a clinician's guide to diagnosis, risk stratification, and treatment.
Wintering A, Dvorak CC, Stieglitz E, Loh ML. Wintering A, et al. Blood Adv. 2021 Nov 23;5(22):4783-4793. doi: 10.1182/bloodadvances.2021005117. Blood Adv. 2021. PMID: 34525182 Free PMC article.
Integrated in silico MS-based phosphoproteomics and network enrichment analysis of RASopathy proteins.
Montero-Bullón JF, González-Velasco Ó, Isidoro-García M, Lacal J. Montero-Bullón JF, et al. Orphanet J Rare Dis. 2021 Jul 6;16(1):303. doi: 10.1186/s13023-021-01934-x. Orphanet J Rare Dis. 2021. PMID: 34229750 Free PMC article.

1. Emanuel PD. Juvenile myelomonocytic leukemia. Curr Hematol Rep. 2004;3:203–9. - PubMed
1. Tartaglia M, Niemeyer CM, Fragale A, Song X, Buechner J, Jung A, et al. Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia. Nat Genet. 2003;34:148–50. - DOI
1. Niemeyer CM, Kang MW, Shin DH, Furlan I, Erlacher M, Bunin NJ, et al. Germline CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemia. Nat Genet. 2010;42:794–800. - DOI
1. Niemeyer CM, Flotho C. Juvenile myelomonocytic leukemia: who’s the driver at the wheel? Blood. 2019;133:1060–70. - DOI
1. Sakaguchi H, Okuno Y, Muramatsu H, Yoshida K, Shiraishi Y, Takahashi M, et al. Exome sequencing identifies secondary mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia. Nat Genet. 2013;45:937–41. - DOI